109 related articles for article (PubMed ID: 11959188)
1. Use of cytomegalovirus antigenemia as a marker for preemptive treatment.
Guirado L; Herreros MA; Muñoz JM; Rabella N; Facundo C; Agraz I; Díaz M; Diaz JM; Durán F; Solà R
Transplant Proc; 2002 Feb; 34(1):67-8. PubMed ID: 11959188
[No Abstract] [Full Text] [Related]
2. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus infection in kidney transplant recipients: early diagnosis and monitoring of antiviral therapy by the antigenemia assay.
Said T; Nampoory MR; Pacsa AS; Johny KV; Nair MP; Abdel-Haleem M; Samhan M; Al-Mousawi M
Transplant Proc; 2001 Aug; 33(5):2799-801. PubMed ID: 11498164
[No Abstract] [Full Text] [Related]
4. Preemptive therapy for the prevention of cytomegalovirus disease following heart transplantation directed by PP65 antigenemia.
Villa M; Lage E; Ballesteros S; Cañas E; Sánchez M; Ordóñez A; Borrego JM; Hinojosa R; Cisneros JM
Transplant Proc; 2003 Mar; 35(2):732-4. PubMed ID: 12644115
[No Abstract] [Full Text] [Related]
5. Is preemptive therapy for CMV infection following liver transplantation superior to symptom-triggered treatment?
Rayes N; Seehofer D; Schmidt CA; Müller AR; Steinmüller T; Bechstein WO; Neuhaus P
Transplant Proc; 2001; 33(1-2):1804. PubMed ID: 11267520
[No Abstract] [Full Text] [Related]
6. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
[TBL] [Abstract][Full Text] [Related]
7. Quantitative CMV-antigenemia test in the diagnosis of CMV infection and in the monitoring of response to antiviral treatment in liver transplant recipients.
Lautenschlager I; Höckerstedt K; Salmela K
Transplant Proc; 1994 Jun; 26(3):1719-20. PubMed ID: 8030100
[No Abstract] [Full Text] [Related]
8. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M
Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus infection after liver transplantation using different prophylaxes.
Kornberg A; Grube T; Hommann M; Schotte U; Scheele J
Transplant Proc; 2001; 33(7-8):3624-5. PubMed ID: 11750539
[No Abstract] [Full Text] [Related]
10. Cytomegalovirus reactivation and preemptive therapy after liver transplant.
Davoudi S; Kasraianfard A; Ahmadinejad Z; Najafi A; Salimi J; Makarem J; Sohrabpour AA; Jafarian A
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():72-5. PubMed ID: 24635797
[TBL] [Abstract][Full Text] [Related]
11. Clinical correlates of pp65 antigenemia monitoring in the first months of post kidney transplant in patients undergoing universal prophylaxis or preemptive therapy.
Carvalho FR; Cosendey RI; Souza CF; Medeiros T; Menezes PA; Silva AA; Almeida JR; Lugon JR
Braz J Infect Dis; 2017; 21(1):51-56. PubMed ID: 27888673
[TBL] [Abstract][Full Text] [Related]
12. Relation between pp65 antigenemia, RT-PCR and viruria for cytomegalovirus detection in kidney transplant recipients.
Solà R; Rabella N; Guirado LL; Díaz JM; Facundo C; García R
Transplant Proc; 2005 Nov; 37(9):3768-9. PubMed ID: 16386533
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation.
Rayes N; Seehofer D; Schmidt CA; Oettle H; Müller AR; Steinmüller T; Settmacher U; Bechstein WO; Neuhaus P
Transplantation; 2001 Sep; 72(5):881-5. PubMed ID: 11571454
[TBL] [Abstract][Full Text] [Related]
14. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
[TBL] [Abstract][Full Text] [Related]
15. Virological diagnosis of cytomegalovirus in renal transplantation: comparison of three diagnostic methods: DNA in plasma by PCR, PP65 leukocytic antigenemia, and viremia.
Eckart P; Brouard J; Legoff C; Freymuth F; Duhamel JF; Ryckelynck JP; Hurault De Ligny B
Transplant Proc; 1996 Oct; 28(5):2806-7. PubMed ID: 8908069
[No Abstract] [Full Text] [Related]
16. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.
Solano C; Muñoz I; Gutiérrez A; Farga A; Prósper F; García-Conde J; Navarro D; Gimeno C
J Clin Microbiol; 2001 Nov; 39(11):3938-41. PubMed ID: 11682510
[TBL] [Abstract][Full Text] [Related]
17. The effect of cytomegalovirus antigenemia titer on the efficacy of preemptive therapy for the prevention of cytomegalovirus disease after kidney transplantation.
Jung GO; Kim SJ; Choi GS; Moon JI; Kim JM; Sin MJ; Kim EY; Kwon CH; Joh JW; Lee SK
Transplant Proc; 2010 Apr; 42(3):804-10. PubMed ID: 20430177
[TBL] [Abstract][Full Text] [Related]
18. Utility of the pp65 direct antigenemia test in the diagnosis of cytomegalovirus (CMV) in renal transplant recipients.
Sharma AK; Taylor JD; Tong W; Brown MW; Sells RA; Bakran A
Transplant Proc; 1997; 29(1-2):799. PubMed ID: 9123531
[No Abstract] [Full Text] [Related]
19. Use of the cytomegalovirus pp65 antigenemia assay for preemptive therapy in allogeneic hematopoietic stem cell transplantation: a real-world review.
Tan BH; Chlebicka NL; Low JG; Chong TY; Chan KP; Goh YT
Transpl Infect Dis; 2008 Oct; 10(5):325-32. PubMed ID: 18627578
[TBL] [Abstract][Full Text] [Related]
20. Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors.
Grossi P; Kusne S; Rinaldo C; St George K; Magnone M; Rakela J; Fung J; Starzl TE
Transplantation; 1996 Jun; 61(11):1659-60. PubMed ID: 8669117
[No Abstract] [Full Text] [Related]
[Next] [New Search]
